Clinical Trial Update: A Clinical Study of T3011 in Subjects With Advanced Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a Phase 1/2 study of T3011 in patients with melanoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• T3011

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Advanced Melanoma | Phase 1, Phase 2 | Status: RECRUITING